Hasegawa, Yumi
Honbo, Masato
Miyata, Kazunori
Oshika, Tetsuro
Article History
Received: 31 August 2021
Accepted: 10 January 2022
First Online: 24 January 2022
Competing interests
: Dr. Kazunori Miyata received research support from Santen Pharmaceutical, Alcon, Senju Pharmaceutical, Johnson & Johnson Vision, HOYA, KOWA Pharmaceutical, Otsuka Pharmaceutical, Novartis, Bayer, Chugai, Kissei, and Japan Tissue Engineering. Dr. Tetsuro Oshika received compensation as a consultant from Alcon, Johnson & Johnson Vision, Santen Pharmaceutical, and Mitsubishi Tanabe. He received research support from Santen Pharmaceutical, Tomey, Alcon, Senju Pharmaceutical, Johnson & Johnson Vision, HOYA, KOWA Pharmaceutical, Otsuka Pharmaceutical, Novartis, Pfizer, and Topcon. Other authors do not have any conflict of interest.